コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erase inhibitor and blocked by coexposure to geranylgeranyl pyrophosphate.
2 und to be reversible on supplementation with geranylgeranyl pyrophosphate.
3 d endothelial apoptosis and were reversed by geranylgeranyl pyrophosphate.
4 at high concentrations that are reversed by geranylgeranyl pyrophosphate.
6 [(3)H]geranylgeranyl monophosphate and [(3)H]geranylgeranyl pyrophosphate ([(3)H]GG-P-P) in CTP-depen
8 ects were absent in slices co-incubated with geranylgeranyl pyrophosphate, a mevalonate product that
10 This inhibitory effect was reversed with geranylgeranyl pyrophosphate, an isoprenoid intermediate
11 ation and was employed for detection of both geranylgeranyl pyrophosphate and a secondary oxysterol s
12 ibitor lovastatin depletes cellular pools of geranylgeranyl pyrophosphate and farnesol pyrophosphate
13 rations of isoprenoid intermediates, such as geranylgeranyl pyrophosphate and farnesyl pyrophosphate.
14 cretion and mRNA levels, effects reversed by geranylgeranyl pyrophosphate and mimicked by inhibiting
15 mevalonate and by the downstream isoprenoid, geranylgeranyl pyrophosphate and not by farnesyl pyropho
17 revented by mevalonate and by the isoprenoid geranylgeranyl pyrophosphate but not by cholesterol.
18 to simvastatin were blocked by mevalonate or geranylgeranyl pyrophosphate but not by farnesyl pyropho
19 nthesis pathway intermediates mevalonate and geranylgeranyl pyrophosphate but not squalene, indicatin
20 f simvastatin was reversed by mevalonate and geranylgeranyl pyrophosphate but not squalene, indicatin
21 ersed by cotreatment with mevalonolactone or geranylgeranyl-pyrophosphate, but not by farnesyl-pyroph
22 molecules including farnesyl pyrophosphate, geranylgeranyl pyrophosphate, cholesterol, and oxysterol
23 nprecedented evidence that-like immune cells-geranylgeranyl-pyrophosphate depletion and thus inhibiti
27 both geranylgeranyl and farnesyl groups from geranylgeranyl pyrophosphate (GGPP) and farnesyl pyropho
28 isoprenoids farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are synthetic precur
29 he isoprenyl precursors, mevalonic acid, and geranylgeranyl pyrophosphate (GGpp) attenuated the stati
30 fer with a lower efficiency than FPP whereas geranylgeranyl pyrophosphate (GGPP) does not transfer at
31 trations of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) in cultured cells.
32 nce that the FPP-derived, 20-carbon molecule geranylgeranyl pyrophosphate (GGPP) is a potent endogeno
33 cessing and prevents RhoB upregulation while geranylgeranyl pyrophosphate (GGPP) restores Rap1a proce
34 ferase domain-containing protein-1) utilizes geranylgeranyl pyrophosphate (GGpp) to synthesize vitami
36 d by farnesyl pyrophosphate (FPP) but not by geranylgeranyl pyrophosphate (GGPP), implicating perturb
37 trong anion dependence were competitive with geranylgeranyl pyrophosphate (GGPP), rather than with th
38 metabolites farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), which are used for
39 in this article that downstream depletion of geranylgeranyl pyrophosphate (GGPP), which is required f
44 the presence or absence of mevalonate (MVA), geranylgeranyl-pyrophosphate (GGPP) and farnesyl-pyropho
47 are completely reversed by mevalonate and by geranylgeranyl pyrophosphate, implicating geranylgeranyl
48 oli, to esterify bacteriochlorophyllide with geranylgeranyl pyrophosphate in vitro, thereby generatin
50 Pases with isoprenoid molecules derived from geranylgeranyl pyrophosphate or farnesyl pyrophosphate i
52 n of isoprenoids (farnesyl-pyrophosphate and geranylgeranyl-pyrophosphate) rather than cholesterol in
57 of transcription 1), a downstream target of geranylgeranyl pyrophosphate signaling, was enhanced.
58 12% identical amino acid sequences with the geranylgeranyl pyrophosphate synthase (GGPPS) of fungi,
59 mal membrane 22PMP, the mammalian homolog of geranylgeranyl pyrophosphate synthase, an mRNA related t
60 ere we report the crystal structure of human geranylgeranyl pyrophosphate synthase, the first mammali
62 or the inhibition of tube formation, whereas geranylgeranyl pyrophosphate, the substrate for the gera
66 imvastatin was blocked after incubation with geranylgeranyl-pyrophosphate to circumvent loss of isopr
67 ication by regulating the cellular levels of geranylgeranyl pyrophosphate, we demonstrate that the im
68 or farnesyl pyrophosphate and its derivative geranylgeranyl pyrophosphate were also increased in the
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。